General Information and Variability Data of DT
DT ID DTD0031
Gene Name SLCO2B1
Protein Name Organic anion transporting polypeptide 2B1
Synonyms KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1
Gene ID
11309
UniProt ID
O94956
TCDB ID
2.A.60.1.20
DT Family Organo Anion Transporter (OAT) Family ;
Tissue Specificity Isoform 1 has it's highest expression inbrain, it is the major form expressed in duodenum, kidney,placenta, and skeletal muscle. Isoform 3 predominates in liver.
Function This Na(+)-independent transporter mediates the transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.
Disease(s) Diabetes [ICD-11: 5A10-5A14]
Dry eye disease [ICD-11: 9A79]
Dyslipidaemias [ICD-11: 5C8Z]
High blood pressure [ICD-11: BA00]
Human immunodeficiency virus infection [ICD-11: 1C62.Z]
Medical abortion [ICD-11: JA00.1]
Open angle glaucoma [ICD-11: 9C61]
Pulmonary arterial hypertension [ICD-11: BB01.0]
Renal cell carcinoma [ICD-11: 2C90]
Genetic Polymorphisms & Epigenetic Regulations of DT
Species-, Tissue- and Disease-specific Protein Abundances of DT
Exogenous Factor Altering DT Activity
Approved Drug(s) Transported by This DT Abiraterone acetate Drug Info Prostate cancer [ICD-11: 2C82] Approved [1]
Aliskiren fumarate Drug Info High blood pressure [ICD-11: BA00] Approved [2]
Atorvastatin Drug Info Hyperlipidaemia [ICD-11: 5C8Z] Approved [3]
Bosentan Drug Info Pulmonary arterial hypertension [ICD-11: BB01.0] Approved [4]
Cerivastatin Drug Info Hyperlipidaemia [ICD-11: 5C8Z] Approved [5]
Dehydroepiandrosterone sulfate Drug Info Dyspareunia [ICD-11: GA12] Approved [6]
Digoxin Drug Info Arrhythmias [ICD-11: BC60-BC9Z] Approved [7]
Dinoprostone Drug Info Medical abortion [ICD-11: JA00.1] Approved [8]
Eltrombopag Drug Info Idiopathic thrombocytopenic purpura [ICD-11: 3B64.10] Approved [9]
Estrone sulfate Drug Info Menopausal symptoms [ICD-11: MF32] Approved [10]
Etoposide Drug Info Testicular cancer [ICD-11: 2C80] Approved [11]
Fexofenadine Drug Info Allergic rhinitis [ICD-11: CA08.0] Approved [12]
Fluvastatin Drug Info Hypercholesterolemia [ICD-11: 5C80.0] Approved [10]
Glibenclamide Drug Info Diabetes [ICD-11: 5A10-5A14] Approved [13]
L-glutamic acid Drug Info Schizophrenia [ICD-11: 6A20] Approved [14]
Latanoprost Drug Info Open angle glaucoma [ICD-11: 9C61] Approved [15]
Latanoprostene bunod Drug Info Renal cell carcinoma [ICD-11: 2C90] Approved [15]
Lifitegrast Drug Info Dry eye disease [ICD-11: 9A79] Approved [16]
Mesalazine Drug Info Recurrent ventricular fibrillation [ICD-11: BC71.1] Approved [17]
Montelukast Drug Info Asthma [ICD-11: CA23] Approved [18]
Pemetrexed Drug Info Malignant pleural mesothelioma [ICD-11: 2C26.0] Approved [19]
Pitavastatin Drug Info Primary hyperlipidemia and mixed dyslipidemia [ICD-11: 5C8Z] Approved [20]
Pitavastatin calcium Drug Info Dyslipidaemias [ICD-11: 5C8Z] Approved [21]
Pravastatin Drug Info Hypercholesterolemia [ICD-11: 5C80.0] Approved [22]
Ritonavir Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [23]
Rocuronium Drug Info Muscle relaxant [ICD-11: XM31L2] Approved [7]
Rosuvastatin Drug Info Hypercholesterolemia [ICD-11: 5C80.0] Approved [24]
Sulfasalazine Drug Info Rheumatoid arthritis [ICD-11: FA20] Approved [25]
Telmisartan Drug Info High blood pressure [ICD-11: BA00] Approved [26]
Clinical Trial Drug(s) Transported by This DT Benzylpenicillin Drug Info Gram-positive bacteria infections [ICD-11: 1A00-1H0Z] Phase 4 [8]
M17055 Drug Info Diuretic vasodilator [ICD-11: BA00] Phase 3 [27]
Talinolol Drug Info Gastrointestinal motility disorder [ICD-11: DE2Z] Phase 1 [28]
Withdrawn, Discontinued or Preclinical Drug(s) Transported by This DT Scutellarin Drug Info Cerebrovascular ischaemia [ICD-11: 8B1Z] Preclinical [29]
Sodium taurocholate Drug Info Type 2 diabetes [ICD-11: 5A11] Preclinical [22]
Taurocholic acid Drug Info Type 2 diabetes [ICD-11: 5A11] Terminated [22]
Endogenous Substrate(s) Organoanions
Drug-DT Affinity Assessed by Cell Line
Drug(s) with Drug-DT Affinity Data Atorvastatin Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 2.84 microM [30]
Atorvastatin Drug Info Madin-Darby canine kidney cells (MDCKII)-OATP2B1 Km = 0.2 microM [31]
Bosentan Drug Info Chinese hamster ovary (CHO) cells-OATP2B1 Km = 202 microM [4]
Bromsulphthalein Drug Info Oocytes-OATP2B1 Km = 0.7 microM [32]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 1.56 microM [33]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 7.14 microM [13]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 8.09 microM [22]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 10.2 microM [10]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 12.5 microM [34]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 13.1 microM [22]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 20.9 microM [21]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 38.24 microM [30]
Estrone sulfate Drug Info Human enterocyte-like 2 cells (Caco-2)-OATP2B1 Km = 1.81 microM [33]
Estrone sulfate Drug Info Oocytes-OATP2B1 Km = 6.3 microM [32]
Fluvastatin Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 0.75 microM [10]
Glibenclamide Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 6.26 microM [13]
Mesalazine Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 188.9 microM [17]
Pitavastatin calcium Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 1.17 microM [21]
Pravastatin Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 2250 microM [22]
Rosuvastatin Drug Info Human cervical cancer cell line (Hela)-OATP2B1 Km = 2.4 microM [35]
Rosuvastatin Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 6.42 microM [24]
Sodium taurocholate Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 71.8 microM [22]
Taurocholic acid Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 71.8 microM [22]
Telmisartan Drug Info Human embryonic kidney cells (HEK293)-OATP2B1 Km = 1.09 microM [26]
References
1 The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate. 2017 May;77(13):1303-1311.
2 Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren. Br J Clin Pharmacol. 2011 May;71(5):718-26.
3 Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos. 2009 May;37(5):1129-37.
4 Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos. 2007 Aug;35(8):1400-7.
5 pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. Mol Pharm. 2011 Aug 1;8(4):1303-13.
6 Expression of OATP family members in hormone-related cancers: potential markers of progression. PLoS One. 2011;6(5):e20372.
7 Drug Interactions in Infectious Diseases.
8 Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60.
9 Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. Drug Metab Dispos. 2011 Jun;39(6):1088-96.
10 Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metab Dispos. 2007 Aug;35(8):1308-14.
11 Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells. Br J Pharmacol. 2012 Mar;165(6):1836-1847.
12 The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics. 2011 Feb;21(2):84-93.
13 Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005 Apr;33(4):518-23.
14 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.60.1.20)
15 The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. Invest Ophthalmol Vis Sci. 2010 May;51(5):2504-11.
16 Clinical Pharmacology and Biopharmaceutics review(s)
17 Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metab Dispos. 2011 Jun;39(6):1097-102.
18 Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans. J Clin Pharmacol. 2013 Nov;53(11):1186-93.
19 Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1). Mol Pharmacol. 2012 Feb;81(2):134-42.
20 Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. Drug Metab Pharmacokinet. 2011;26(2):171-9.
21 Drug-drug interaction between pitavastatin and various drugs via OATP1B1. Drug Metab Dispos. 2006 Jul;34(7):1229-36.
22 Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther. 2004 Feb;308(2):438-45.
23 pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions. J Pharmacol Exp Ther. 2010 Sep 1;334(3):1009-22.
24 Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos. 2008 Oct;36(10):2014-23.
25 Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP. J Pharm Sci. 2017 Sep;106(9):2688-2694.
26 Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Drug Metab Dispos. 2008 Apr;36(4):796-805.
27 Characterization of the uptake mechanism for a novel loop diuretic, M17055, in Caco-2 cells: involvement of organic anion transporting polypeptide (OATP)-B. Pharm Res. 2007 Jan;24(1):90-8.
28 Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J Pharmacol Exp Ther. 2010 Jan;332(1):181-9.
29 Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics. Drug Metab Dispos. 2012 Oct;40(10):2009-20.
30 Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J Med Chem. 2012 May 24;55(10):4740-63.
31 Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther. 2006 Dec;80(6):607-20.
32 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
33 Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab Dispos. 2006 Aug;34(8):1423-31.
34 Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res. 2001 Sep;18(9):1262-9.
35 Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006 May;130(6):1793-806.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.